This is an excerpt from a member-only article. To read the article in its entirety, please login
Employee compliance rises as medicine copays drop
Incorporating a value-based insurance design (VBID) can increase the use of important medications, according to a new study. The approach complements not only disease management programs but CDHPs as well.
The study, led by a team of University of Michigan and Harvard University researchers and published in the January/February Health Affairs, showed that a large private employer significantly increased its employees' use of important chronic-disease medicines by making some free and reducing copays for others. Another employer that kept its copays the same (the control group) didn't experience the same increase.